Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia
scientific article published on 13 February 2007
Author/s
author: Andreas Hochhaus, Catherine Roche-Lestienne, Michela Rondoni, Claude Preudhomme, Giuseppe Saglio, Georgia Metzgeroth, Giovanni Martinelli, Emanuela Ottaviani, Jane F Apperley, Daniela Cilloni, Enrico Gottardi, Philipp Erben
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.